Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

Sponsor
Mayo Clinic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05343000
Collaborator
(none)
15
1
1
6.9
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to develop a data driven system for persons with severe obesity sleep apnea that utilizes remote monitoring with health coaching to create behavior changes aimed at improving health and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Home-based pulmonary rehabilitation (PR) system
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pilot studyPilot study
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Lifestyle Program for Severe Comorbid Obstructive Sleep Apnea With Severe Obesity
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Severe Comorbid OSA

Newly-diagnosed severe comorbid obstructive sleep apnea subjects will use technology to facilitate remote health coaching through a home-based pulmonary rehabilitation (PR) system

Behavioral: Home-based pulmonary rehabilitation (PR) system
Technology to facilitate remote health coaching through PAP management, sleep scheduling, sleep duration, diet, exercise, medication and more. The tablet and sensors upload the patient's activities, physiological data, and answers to the daily self-report questions to a secure website. This website also allows health coaches to view patient data via overview, weekly, daily, and trend reports. Health coaches call patients regularly to celebrate progress, assist with any issues, and set new goals.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of proposed system in patients with OSA and Obesity [Qualitative Interviews will be completed at the end of the two week trial]

    Qualitative Interview

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients, 18 years of age or older.

  • Newly diagnosed with severe Obstructive Sleep Apnea (OSA) and severe obesity (BMI > 35).

Exclusion Criteria:
  • Individuals < 18 years of age.

  • Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic in Rochester Rochester Minnesota United States 55905

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Roberto Benzo, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Roberto P. Benzo, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT05343000
Other Study ID Numbers:
  • 21-011497
First Posted:
Apr 25, 2022
Last Update Posted:
Apr 25, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 25, 2022